eruptive < erysipelas < erysipeloid

Facettes : Author.f AffOrg.f AffPays.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
000079 (2013)	D. Picard ; A. Klein ; S. Grigioni [France] ; P. Joly	Risk factors for abscess formation in patients with superficial cellulitis (erysipelas) of the leg
000384 (2012)		Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the U.K. Dermatology Clinical Trials Network’s PATCH II trial
000385 (2012)	O. Chosidow [France] ; L. Le Cleach [France]	Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg. A commentary
000715 (2011)	K. Krasagakis ; G. Samonis [Grèce] ; A. Valachis [Grèce] ; P. Maniatakis ; G. Evangelou ; A. Tosca	Local complications of erysipelas: a study of associated risk factors
000950 (2010)	Konstantin Krasagakis ; Antonios Valachis [Grèce] ; Panagiotis Maniatakis ; Sabine Krüger-Krasagakis ; George Samonis [Grèce] ; Androniki D. Tosca	Report: Analysis of epidemiology, clinical features and management of erysipelas
000C19 (2009)	Stefanie Reich-Schupke [Allemagne] ; Alexander Kreuter [Allemagne] ; Peter Altmeyer [Allemagne] ; Markus Stücker [Allemagne]	Wrong diagnosis erysipelas: hypodermitis – case series and review of literature
000C40 (2009)	P. E. Pertel [États-Unis] ; B. I. Eisenstein [États-Unis] ; A. S. Link [États-Unis] ; B. Donfrid [Serbie] ; E. J. A. Biermann [Afrique du Sud] ; P. Bernardo [États-Unis] ; W. J. Martone [États-Unis]	The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas
000C84 (2009)	C. Bachmeyer [France] ; E. Begon ; P. Martres [France] ; L. Blum	Relapsing erysipelas of the buttock due to Streptococcus agalactiae in an immunocompetent woman
001045 (2008)	Wolfgang Weyers [Allemagne] ; Carlos Diaz-Cascajo [Allemagne] ; Peter Preinfalk [Allemagne] ; Harald Löffler [Allemagne]	Mycosis fungoides mimicking erysipelas
001116 (2008)	R. J. Damstra ; M. A. M. Van Steensel [Pays-Bas] ; J. H. B. Boomsma [Pays-Bas] ; P. Nelemans [Pays-Bas] ; J. C. J. M. Veraart [Pays-Bas]	Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg
001634 (2006)	S. Vignes [France] ; A. Dupuy [France]	Recurrence of lymphoedema‐associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study
001671 (2006)	N. H. Cox [Royaume-Uni]	Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow‐up
001811 (2006)	Wg Goettsch ; Jn Bouwes Bavinck [Pays-Bas] ; Rmc Herings [Pays-Bas]	Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands
001E55 (2004)	Felix Pavlotsky [Israël] ; Shalom Amrani [Israël] ; Henry Trau [Israël]	Recurrent erysipelas: risk factors
002014 (2004)	M. Fischer [Allemagne] ; K. Benndorf [Allemagne] ; E. Drunkenmölle [Allemagne] ; Wch Marsch [Allemagne]	Localized mucinosis subsequent to erysipelas
002577 (2002)	Philippe Bernard [France] ; Olivier Chosidow [France] ; Loíc Vaillant [France]	Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial
003267 (2000)		Consensus conference on Erysipelas and necrotizing fasciitis: management
003616 (1999)	Alain Dupuy [France] ; Hakima Benchikhi [France] ; Jean-Claude Roujeau [France] ; Philippe Bernard [France] ; Loïc Vaillant [France] ; Olivier Chosidow ; Bruno Sassolas ; Jean-Claude Guillaume ; Jean-Jacques Grob [France] ; Sylvie Bastuji-Garin	Risk factors for erysipelas of the leg (cellulitis): case-control study
003878 (1999)	M. Heim [Israël] ; M. Wershavski [Israël] ; I. Siev-Ner [Israël] ; M. Azaria [Israël]	A late complication of erysipelas
003A60 (1998)	H. Dobrev [Bulgarie]	Use of Cutometer to assess dermal oedema in erysipelas of the lower legs
004B26 (1994)	Michal Lotem [Israël] ; Gabriel Tamir [Israël] ; David Loven [Israël] ; Michael David [Israël] ; Daniel Hauben [Israël]	Multiple basal cell carcinomas of the leg after recurrent erysipelas and chronic lymphedema

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "erysipelas" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "erysipelas" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    erysipelas
}}

---

This area was generated with Dilib version V0.6.31. Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024